1. Pierre Legault

    0 Comments Leave a Comment

    1-2 of 2
    1. Mentioned In 2 Articles

    2. Adynxx Completes Merger with Alliqua BioMedical, Adds Pierre Legault and Matt Ruth to Board of Directors

      Adynxx Completes Merger with Alliqua BioMedical, Adds Pierre Legault and Matt Ruth to Board of Directors
      SAN FRANCISCO, May 06, 2019 (GLOBE NEWSWIRE) -- Adynxx, Inc. (Nasdaq: ADYX), a clinical-stage biopharmaceutical company leading the development of transcription factor decoy technology and first-in-class therapeutics for the treatment of pain and inflammatory diseases, today announced the completion of its merger with Alliqua BioMedical, Inc...
      Read Full Article
    3. 1-2 of 2
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Quotes

    1. Dr. Taglietti has an impressive track record of leading global R&D operations, and has overseen the development and worldwide approvals of dozens of important therapeutic products.
      In NephroGenex Appoints Marco Taglietti, M.D. to Board of Directors
    2. Throughout my career I have chosen board appointments very carefully, and I see a tremendous opportunity in Regado. As the company continues to drive toward clinical success with REG1, I look forward to offering my expertise and guidance.
      In Regado Biosciences, Inc. Adds Global Pharmaceutical Business Veteran to Board of Directors
  3. Quotes about Pierre Legault

    1. I am very pleased to welcome Pierre Legault to our board of directors.
      In Syndax Pharmaceuticals (SNDX) Names Pierre Legault to Board of Directors